![Oxford BioMedica PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/lse/oxb.png?tr=w-200)
Oxford BioMedica PLC
LSE:OXB
![Oxford BioMedica PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/lse/oxb.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/lse/oxb.png)
Oxford BioMedica PLC
Depreciation & Amortization
Oxford BioMedica PLC
Depreciation & Amortization Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/cnta.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/autl.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/bcyc.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/imcr.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/lse/gns.png)
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Oxford BioMedica PLC
LSE:OXB
|
Depreciation & Amortization
ÂŁ28.7m
|
CAGR 3-Years
43%
|
CAGR 5-Years
46%
|
CAGR 10-Years
39%
|
![]() |
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Depreciation & Amortization
$810k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Depreciation & Amortization
$6.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Depreciation & Amortization
$6.6m
|
CAGR 3-Years
72%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
![]() |
Immunocore Holdings PLC
NASDAQ:IMCR
|
Depreciation & Amortization
ÂŁ4.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
![]() |
Genus PLC
LSE:GNS
|
Depreciation & Amortization
ÂŁ45.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
See Also
What is Oxford BioMedica PLC's Depreciation & Amortization?
Depreciation & Amortization
28.7m
GBP
Based on the financial report for Dec 31, 2023, Oxford BioMedica PLC's Depreciation & Amortization amounts to 28.7m GBP.
What is Oxford BioMedica PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
39%
Over the last year, the Depreciation & Amortization growth was 9%. The average annual Depreciation & Amortization growth rates for Oxford BioMedica PLC have been 43% over the past three years , 46% over the past five years , and 39% over the past ten years .